Citadel Advisors’s Tenon Medical TNON Stock Holding History
Bought
Maintained
Sold
Other funds holding TNON
VCM
VFT
SS
SAMC
TRCT
Citadel Advisors's TNON Position: Q1 2026 in Review
Citadel Advisors sold out of Tenon Medical (TNON) in Q1 2026, closing a stake of 636 shares — an estimated $21.2K sold.
Citadel Advisors first reported a position in TNON in Q2 2022 and held it in 4 quarters. The position peaked at $53K in Q2 2022. 12 funds tracked by Wall St. Rank hold TNON as of Q1 2026.
- Citadel Advisors reported no remaining Tenon Medical position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 636 Tenon Medical shares in Q1 2026, an estimated $21.2K.
- Citadel Advisors first reported a position in Tenon Medical in Q2 2022 and held it in 4 quarters.
- Citadel Advisors's Tenon Medical position peaked at $53K in Q2 2022.
- 12 funds tracked by Wall St. Rank held Tenon Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.